全文获取类型
收费全文 | 158062篇 |
免费 | 47411篇 |
国内免费 | 192篇 |
专业分类
耳鼻咽喉 | 2585篇 |
儿科学 | 6203篇 |
妇产科学 | 2388篇 |
基础医学 | 26458篇 |
口腔科学 | 8103篇 |
临床医学 | 18661篇 |
内科学 | 43476篇 |
皮肤病学 | 9229篇 |
神经病学 | 20283篇 |
特种医学 | 4199篇 |
外科学 | 25113篇 |
综合类 | 405篇 |
一般理论 | 56篇 |
预防医学 | 11689篇 |
眼科学 | 2845篇 |
药学 | 11189篇 |
中国医学 | 1319篇 |
肿瘤学 | 11464篇 |
出版年
2023年 | 529篇 |
2022年 | 391篇 |
2021年 | 2641篇 |
2020年 | 5814篇 |
2019年 | 12221篇 |
2018年 | 12232篇 |
2017年 | 12675篇 |
2016年 | 13368篇 |
2015年 | 13770篇 |
2014年 | 13872篇 |
2013年 | 15388篇 |
2012年 | 11164篇 |
2011年 | 11379篇 |
2010年 | 12090篇 |
2009年 | 7623篇 |
2008年 | 8286篇 |
2007年 | 7422篇 |
2006年 | 7424篇 |
2005年 | 6924篇 |
2004年 | 6371篇 |
2003年 | 5888篇 |
2002年 | 5727篇 |
2001年 | 2685篇 |
2000年 | 3184篇 |
1999年 | 1592篇 |
1998年 | 376篇 |
1997年 | 280篇 |
1996年 | 276篇 |
1995年 | 250篇 |
1994年 | 205篇 |
1993年 | 188篇 |
1992年 | 310篇 |
1991年 | 292篇 |
1990年 | 217篇 |
1989年 | 226篇 |
1988年 | 154篇 |
1987年 | 145篇 |
1986年 | 154篇 |
1985年 | 159篇 |
1984年 | 163篇 |
1983年 | 115篇 |
1982年 | 127篇 |
1981年 | 107篇 |
1980年 | 112篇 |
1979年 | 90篇 |
1978年 | 76篇 |
1976年 | 57篇 |
1975年 | 54篇 |
1974年 | 69篇 |
1973年 | 66篇 |
排序方式: 共有10000条查询结果,搜索用时 6 毫秒
81.
82.
Luis Veloza Cristina Teixido Natalia Castrejon Fina Climent Ana Carri Marta Marginet Davide Soldini Blanca Gonzlez‐Farr Inmaculada Ribera‐Cortada Armando Lopez‐Guillermo Eva Gonzlez‐Barca Adriana Sierra Mileyka Herrera Cndida Gmez Adriana Garcia Olga Balagu Elias Campo Antonio Martinez 《Histopathology》2019,75(6):799-812
83.
Leyi Wang Saraswathi Lanka Debbie Cassout Nohra E. Mateus‐Pinilla Ganwu Li William C. Wilson Dongwan Yoo Paul Shelton Richard L. Fredrickson 《Transboundary and Emerging Diseases》2019,66(5):1809-1820
First described in 1955 in New Jersey, epizootic haemorrhagic disease (EHD) causes a severe clinical disease in wild and domestic ruminants worldwide. Epizootic haemorrhagic disease outbreaks occur in deer populations each year from summer to late autumn. The etiological agent is EHD virus (EHDV) which is a double‐stranded segmented icosahedral RNA virus. EHD virus utilizes point mutations and reassortment strategies to maintain viral fitness during infection. In 2018, EHDV serotype 2 was predominantly detected in deer in Illinois. Whole genome sequencing was conducted for two 2018 EHDV2 isolates (IL41747 and IL42218) and the sequence analyses indicated that IL42218 was a reassortant between different serotypes whereas IL41747 was a genetically stable strain. Our data suggest that multiple strains contribute to outbreaks each year. 相似文献
84.
85.
86.
87.
Estefany I. Medina-Reyes Carolina Rodríguez-Ibarra Daniel Díaz-Urbina Alejandro Déciga-Alcaraz Normal L. Delgado-Buenrostro Yolanda I. Chirino José Pedraza-Chaverri 《Journal of applied toxicology : JAT》2022,42(8):1411-1419
Food-grade titanium dioxide (E171) is widely used as a food additive, and it is known that after oral consumption, E171 is translocated into the bloodstream reaching the highest titanium level at 6 h. E171 is accumulated in some organs triggering toxicity, but the effects on the blood parameters after oral consumption have been less studied. Recently, evidence shows that oral exposure to E171 induces behavioral signs of anxiety and depression. The relation between blood alterations and psychiatric disorders has been previously demonstrated. However, the oral exposure to E171 effects on alterations in blood parameters and effects linked to alterations in animal behavior has not been explored. In this short communication, we aimed to investigate the effects of E171 on specific blood parameters (hematocrit, hemoglobin, number of erythrocytes, and leukocytes) and anxiety and compulsive-like behavior in males and females orally exposed to ~5 mg/kg for 4 weeks. The results showed that E171 decreased hematocrit and hemoglobin in male but not in female mice while leukocyte and erythrocyte count remained unaltered. Oral consumption of E171 decreased the levels of anxiety-like behavior in females but not in male mice, while compulsive-like behavior was increased in both male and female mice. 相似文献
88.
89.
90.
Tuberculosis (TB) remains one of a major health problem worldwide. Tuberculosis vaccine research has made an extraordinary progress over the past few years. However, there is still no replacement for the Bacillus Calmette‐Guérin vaccine, the only TB vaccine licensed for human use. Therefore, the discovery and development of new TB vaccines remains a priority. This article discusses current strategies used to diversify TB vaccines and includes discussion of the status of efforts to improve protection against Mycobacterium tuberculosis (M tb) infection or TB disease by developing new and safe TB vaccines. This article also highlights the current research efforts in immune‐enhancing approaches to improve vaccination efficacy. The development of more effective TB vaccines might have significant impact on global TB control. 相似文献